{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["15"],"submitter":["Jurcik T"],"pubmed_abstract":["The evidence for the use of Augmented Reality (AR) in treating specific phobias has been growing. However, issues of accessibility persist, especially in developing countries. The current study examined a novel, but relatively simple therapist guided smartphone-based AR Exposure Treatment (ARET) of spider phobia. Participants who reported symptoms of Arachnophobia were randomized into one of three comparison groups: ARET (<i>n</i> = 20), traditional <i>in vivo</i> exposure therapy (IVET; <i>n</i> = 18) and a waitlist control group (<i>n</i> = 17). Behavioral approach, subjective symptom measures, and galvanic skin response were assessed pre- and post-treatment. The study was concluded with a one-month follow up assessment. Results indicated that both treatment groups showed statistically significant and clinically meaningful improvements in behavioral approach at post-test that were maintained at 1 month follow- up, compared to the wait-listed group. Moreover, the treatment groups demonstrated significant improvements in subjective symptom report at 1-month follow up. Given its utility and potential accessibility, our findings suggest that future AR evaluation research could be conducted in therapy settings with minimal resources."],"journal":["Frontiers in psychology"],"pagination":["1214125"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC10911123"],"repository":["biostudies-literature"],"pubmed_title":["The efficacy of augmented reality exposure therapy in the treatment of spider phobia-a randomized controlled trial."],"pmcid":["PMC10911123"],"pubmed_authors":["Adu P","Skuratov A","Samarina I","Kosonogov V","Demchenko A","Jurcik T","Krasavtseva Y","Mohammed AR","Sergeev N","Zaremba-Pike S","Kochetkov Y","Buranova N","Sawada T"],"additional_accession":[]},"is_claimable":false,"name":"The efficacy of augmented reality exposure therapy in the treatment of spider phobia-a randomized controlled trial.","description":"The evidence for the use of Augmented Reality (AR) in treating specific phobias has been growing. However, issues of accessibility persist, especially in developing countries. The current study examined a novel, but relatively simple therapist guided smartphone-based AR Exposure Treatment (ARET) of spider phobia. Participants who reported symptoms of Arachnophobia were randomized into one of three comparison groups: ARET (<i>n</i> = 20), traditional <i>in vivo</i> exposure therapy (IVET; <i>n</i> = 18) and a waitlist control group (<i>n</i> = 17). Behavioral approach, subjective symptom measures, and galvanic skin response were assessed pre- and post-treatment. The study was concluded with a one-month follow up assessment. Results indicated that both treatment groups showed statistically significant and clinically meaningful improvements in behavioral approach at post-test that were maintained at 1 month follow- up, compared to the wait-listed group. Moreover, the treatment groups demonstrated significant improvements in subjective symptom report at 1-month follow up. Given its utility and potential accessibility, our findings suggest that future AR evaluation research could be conducted in therapy settings with minimal resources.","dates":{"release":"2024-01-01T00:00:00Z","publication":"2024","modification":"2026-06-16T04:52:52.751Z","creation":"2025-04-06T17:16:30.577Z"},"accession":"S-EPMC10911123","cross_references":{"pubmed":["38440241"],"doi":["10.3389/fpsyg.2024.1214125"]}}